Radiological risk factors for T2-T3 glottic carcinoma treated with (chemo)radiotherapy—a multicenter analysis

• by Agatha S. Baidun, Yves M. H. F. Gorissen, Martine Hendriksma, Renske Gahrmann, Jose A. Hardillo, Sjoert Pegge, Robert P. Takes, Guido B. van den Broek, Martin A. de Jong, Federica Lucev, Elisabeth V. Sjogren, Berit M. Verbist

• June 19, 2026

A New Era for Pancreatic Cancer: How Baptist Health Research Helped Get Us Here

Pancreatic adenocarcinoma, the most common form of pancreatic cancer, accounts for roughly 90 to 95 percent of cases. It's notoriously difficult to catch early, because symptoms often don't appear until the disease has already spread

• by

• September 24, 2026

• 11 min

Beyond classical boundaries: rethinking ICU access in acute leukemia

• by Guillaume Berton, Norbert Vey

• September 22, 2026

What Medicare Claims Tell Us About Cancer Disparities in American Indian and Alaska Native Peoples

• by Cole Allick, Denise A. Dillard

• October 7, 2026